| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 34,168 | 32,619 | 33,392 | 35,211 | | Cost of Revenue | 6,556 | 6,400 | 6,490 | 6,738 | | | Gross Profit | 27,612 | 26,219 | 26,902 | 28,473 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 25,739 | 22,625 | 16,570 | 20,677 | | Non Recurring |
-
|
-
|
-
| 105,047 | | Others | 22,000 | 48,000 | 15,000 | 61,339 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (20,127) | (44,406) | (4,668) | (158,590) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (20,127) | (44,406) | (4,668) | (158,590) | | Interest Expense | 2,261 | 2,412 | 2,121 | 2,392 | | Income Before Tax | (22,388) | (46,818) | (6,789) | (160,982) | | Income Tax Expense | (9,744) | (18,750) | (2,873) | (23,422) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,644) | (28,068) | (3,916) | (137,560) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,644) | (28,068) | (3,916) | (137,560) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,644) | ($28,068) | ($3,916) | ($137,560) |
|
0.26% Nasdaq 
0.02 (2.86%) 
Income Statement
